R.PR
REGISTERED-PRINCIPAL REGISTER
04/09/2024
Back to search
Official data from USPTO
BLUE PERSIMMON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
BLUE PERSIMMON
ST13
US500000097377830Class
35, 42
Filing
97377830
Registration
7356460
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
04/10/2024
Classification
Registered
Trademark type
Word
Nice classes
35, 42
Filing date
04/23/2022
Registration date
04/09/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/09/2024
Last transaction
04/10/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
08/10/2019
First use in commerce
12/16/2019
Drawing code
4
Owner type
16
Owner location
Washington, DC
Examiner
MAROTTA, GABRIELLE CHRISTINA
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Blue Persimmon Group LLC
Representatives
Kimberly Shin
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting services in the field of biotechnologypharmaceuticalsmedical deviceshealthcarelife sciences; Promoting collaboration within the scientificresearch and medical communities to achieve advances in the field of healthcare; Providing independent review of clinical trials for business purposes; Providing public policy information in the field of biotechnologypharmaceuticalsmedical deviceshealthcarelife sciences
Class 42
Product development consulting in the field of biotechnologypharmaceuticalsmedical deviceshealthcarelife sciences; Scientific research consulting in the field of biotechnologypharmaceuticalsmedical deviceshealthcarelife sciences; Providing scientific information in the field of pharmaceutical drugsbiologicsdigital therapeuticsmedical device development and process validation; Providing scientific research informationscales and standards for measuring patient outcomesin the field of health economics and health outcomes researchepidemiologymedical product clinical trial design; Scientific research relating to the creation of toolsscalesstandards for measuring patient outcomes in the field of health economics and health outcomes researchepidemiologymedical product clinical trial design
Publications
History of USPTO decisions and trademark events.
28 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/09/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/02/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/01/2024
DOCK
ASSIGNED TO EXAMINER
02/28/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/09/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/08/2024
IUAF
USE AMENDMENT FILED
01/18/2024
EISU
TEAS STATEMENT OF USE RECEIVED
01/18/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/07/2023
PUBO
PUBLISHED FOR OPPOSITION
11/07/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/18/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/02/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
09/18/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/18/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
09/18/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/18/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/12/2023
ALIE
ASSIGNED TO LIE
09/11/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/25/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/14/2023
GNRT
NON-FINAL ACTION E-MAILED
02/14/2023
CNRT
NON-FINAL ACTION WRITTEN
02/14/2023
DOCK
ASSIGNED TO EXAMINER
02/10/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/28/2022
NWAP
NEW APPLICATION ENTERED
04/27/2022
Continuous trademark protection
Get notified about every new filing that threatens BLUE PERSIMMON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.